Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deals Of The Year 2022 Winners Revealed

Feb 21 2023

• By Jo Shorthouse

Deal of the year image — • Source: Shutterstock

Related Content

Finance Watch: Public Markets Open Back Up For Biopharma Offerings

Mar 25 2022

Finance Watch: Karuna, Cerevel And Others Benefit From Improving Biotech Sentiment

Aug 12 2022

Nimbus CEO Talks $4bn Takeda Deal And Capital Cycles

Feb 08 2023

Takeda Aims At BMS’s Sotyktu In $4bn Deal For Nimbus’s TYK2 Inhibitor

Dec 13 2022

Amgen To Enhance Rare Disease Franchise With $27.8bn Horizon Takeover

Dec 12 2022

Big Names Backers Give Altos $3bn To Pursue Cell Rejuvenation Science

Jan 19 2022

Related Companies

Takeda Pharmaceutical Co. Ltd.

Nimbus Therapeutics, Inc.

Altos Labs

Karuna Therapeutics, Inc.

argenx N.V.

Amgen, Inc.

Horizon Therapeutics plc

Johnson & Johnson

Additional Topics

Deals Financing M & A Growth Companies Commercial BioPharmaceutical

More from Deal-Making

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window